Drug Approval | August 05, 2023
USFDA approves Merck’s ERVEBO for use in children 12 months of age and older
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Take proper precautions and seek timely treatment!
Uses a simple mechanical approach for removing intrauterine tissues
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Subscribe To Our Newsletter & Stay Updated
